CClinicalTrials.gg
RecruitingNCT05946356Updated Jul 14, 2023

Psychological Wellbeing, Physical Activity, and Disability in Fibromyalgia

An observational study in Fibromyalgia, sponsored by Ahram Canadian University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-14.

Sponsored by Ahram Canadian University · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to investigate the association between psychological wellbeing, physical activity, and disability in patients with fibromyalgia. Participants will complete self-reported questionnaires to assess psychological wellbeing, physical activity, and disability. The study will use descriptive statistics, correlation analysis, and multiple regression analysis to analyze the data.

02

Conditions studied

03

In context

Fibromyalgia

1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 270 observational studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Ahram Canadian University is the lead sponsor of 69 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients diagnosed with fibromyalgia

Inclusion criteria

  • Diagnosis of fibromyalgia
  • Age between 18 and 70 years old

Exclusion criteria

Exclusion Criteria:

  • Unable to complete self-reported questionnaires
  • Presence of other chronic pain conditions
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Fibromyalgia patients

    Participants will complete self-reported questionnaires to assess psychological wellbeing, physical activity, and disability.

    Other: no intervention - cross-sectional observational only

Interventions

  • Otherno intervention - cross-sectional observational only

    no intervention - cross-sectional observational only

06

What researchers measure

Primary outcomes

  1. Depression, Anxiety, and Stress Scale (DASS)

    epression, Anxiety, and Stress Scale (DASS) is a self-report questionnaire that is used to assess the severity of depression, anxiety, and stress. The DASS consists of 42 items that are scored on a scale of 0 to 3, with 0 indicating "not at all" and 3 indicating "severely." The total score for the DASS is the sum of the scores for the 42 items. A higher score indicates more severe symptoms of depression, anxiety, or stress.

    Time frame: Baseline

  2. International Physical Activity Questionnaire (IPAQ)

    International Physical Activity Questionnaire (IPAQ) is a self-report questionnaire that is used to assess physical activity levels. The IPAQ consists of 7 questions that ask about the frequency, duration, and intensity of physical activity. The IPAQ can be used to assess physical activity levels in people of all ages and activity levels.

    Time frame: Baseline

  3. Fibromyalgia Impact Questionnaire (FIQ)

    is a self-report questionnaire that is used to measure disability in patients with fibromyalgia. The FIQ consists of 21 items that ask about the impact of fibromyalgia on physical function, social function, and role function. The FIQ can be used to assess the severity of fibromyalgia and to monitor the effectiveness of treatment.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Outpatient clinic of faculty of physical therapy, Ahram Canadian University
    Al Ḩayy Ath Thāmin, Giza 3221405, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05946356
Lead sponsor
Ahram Canadian University
Responsible party
Mohamed Magdy ElMeligie (Lecturer of Physical Therapy and Director of Electromyography Lab, Ahram Canadian University) — Principal investigator
First posted
Jul 14, 2023
Start date
Jul 15, 2023 (estimated)
Primary completion
Nov 25, 2023 (estimated)
Completion
Dec 1, 2023 (estimated)
Last update
Jul 14, 2023

Study contacts

Mohamed M ElMeligie, Ph.d
Contact
mohamed.elmeligie@acu.edu.eg
+201064442032
Amal Fawzy, Ph.d
study director · Faculty of Physical Therapy, Ahram Canadian University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion